Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats
- 31 March 1992
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 62 (3) , 258-263
- https://doi.org/10.1016/0090-1229(92)90100-3
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 22 references indexed in Scilit:
- Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.The Journal of Experimental Medicine, 1990
- Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue RemodelingScience, 1988
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Tumour necrosis factor-α in murine autoimmune 'lupus' nephritisNature, 1988
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex.The Journal of Experimental Medicine, 1981
- Studies of endotoxin-induced decrease in lipoprotein lipase activity.The Journal of Experimental Medicine, 1981
- STUDIES ON THE GENERALIZED SHWARTZMAN REACTIONThe Journal of Experimental Medicine, 1952